A look back at the advances of 2024

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...

Big changes ahead for myotonic dystrophy treatments

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...

Hope for brain tumour patients

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...

Can Alzheimer’s disease be stopped before it starts?

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...

Crossing the blood-brain barrier to treat MS

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...

Finding the master switch to turn off ALS

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...